The role of renal eicosanoid metabolism in the pathogenesis of idiopathic calcium oxalate urolithiasis

Italian Journal of Mineral and Electrolyte Metabolism

Volumn 10, Issue 2, 1996, Pages 105-118

  Buck, A Colin ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

eicosanoids; fatty acids; hypercalciuria; nephrocalcinosis; prostaglandins; urolithiasis

Indexed keywords

FISH OIL; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2;

ARACHIDONIC ACID METABOLISM; CALCIUM TRANSPORT; DIET; HUMAN; HYPEROXALURIA; NONHUMAN; REVIEW; STONE FORMATION; UROLITHIASIS;

ANIMALIA;

EID: 0030483026     PISSN: 11211709     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. Andersen DA. Environmental factors in the aetiology of urolithiasis. In Urinary Calculi. Proc Int Symp Renal Stone Res 1973;130-44.
2. Yoshida O. Epidemiology of stones in Japan. Jpn J Urol 1979;7:975-83.
3. Robertson WG. Epidemiology of urinary stone disease. Urol Res 1990; 18(Suppl 1)3-8.
4. Schwille PO, Herrmann U. Environmental factors in the pathophysiology of recurrent idiopathic calcium urolithiasis (RCU) with emphasis on nutrition. Urol Res 1992;20:72-83.
5. Andersen DA. Historical and geographical differences in the pattern of incidence of urinary stones considered in relation to possible aetiological factors. In: Hodgkinson A, Nordin BEC, editors. Renal Stone Research Symposium (Leeds 1968). London: J & A Churchill, 1969:7-31.
6. Schumann HJ. Die Häufigkeit der Urolithiasis in Secktionsgut des pathologischen, Institute St. George, Leipzig. Zentralbl Allg Pathol 1963;105:88-94.
7. Iguchi M, Kataoka K, Kohri K, Sunao Y, Kurita T. Nutritional risk factors in calcium stone disease in Japan. Urol Int 1984;39:32-5.
8. Masai M, Ito H, Kotake T. The effect of dietary intake on urinary oxalate excretion in calcium renal stone formers. Br J Urol 1995;76:692-6.
9. Buck AC, Sampson WF, Lote CJ, Blacklock NJ. The influence of renal prostaglandins on glomerular filtration rate (GFR) and calcium excretion in urolithiasis. Br J Urol 1981;53:485-91.
10. Kontessis P, Jones S, Dodds R, Trevisan R, Nosadini R, Fioretto P et al. Renal, metabolic and hormonal responses to ingestion of animal and vegetable protein. Kidney Int 1990;38:136-44.
11. Krishna GG, Newell G, Miller E, Heeger P, Smith R, Polansky M et al. Protein induced glomerular hyperfiltration: Role of hormonal factors. Kidney Int 1988;33:578-83.
12. Hirschberg RR, Zipser RD, Slomowitz LA, Kopple JD. Glucagon and prostaglandins are mediators of amino acid induced rise in renal haemodynamics. Kidney Int 1988;33:1147-55.
13. Paller M, Hostetter TH. Dietary protein increases plasma renin and reduces pressor reactivity to angiotesin II. Am J Physiol 1986;251: F34-9.
14. Stahl RA, Kudelka S, Helmchen U. High protein intake stimulates glomerular prostaglandin formation in remnant kidneys. Am J Physiol 1987;252:F1083-94.
15. Hsueh W, Isakson PC, Needleman P. Hormone selective lipase activation. Prostaglandins 1977;13:1075-91.
16. Bell RL, Kennedy DA, Stanford N, Majerus PW. Diglyceride lipase: a pathway for arachidonate release from human platelets. Proc. Fourth International Prostaglandin Conference. Washington DC, 1979:30.
17. Knapp HR, Oelz O, Jackson-Roberts L, Sweetman BJ, Oates JH, Reed PW. Ionophores stimulate prostaglandin and thromboxane biosynthesis. Proc Natl Acad Sci USA 1977;74:4251-5.
18. Zenser TV, Davis BB. Effects of calcium on prostaglandin E2 synthesis by rat inner medullary slices. Am J Physiol 1978; 235:F213-8.
19. Zenser TV, Herman CA, Davis BB. Effects of calcium and A23187 on renal inner medullary prostaglandin E2 synthesis. Am J Physiol 1980;238:E371-6.
20. Erman A, Raz A. Effects of bivalent cations on prostaglandin biosynthesis and phospholipase A2 action in rabbit kidney medulla slices. Biochem J 1979;182:821-5
21. Craven PA, Briggs R, DeRubertis FR. Calcium dependent action of osmolality on adenosine 3′ 5′ monophosphate accumulation in rat inner medulla: evidence for a relationship to calcium-responsive arachidonate release and prostaglandin synthesis. J Clin Invest 1980;65:529-42.
22. ++-Calmodulin-dependent renal prostaglandin E. Am J Physiol 1981;241:F649-58.
23. Rasmussen H. The calcium messenger system (part 1). N. Engl J Med 1986;314:1094-101
24. Lote CJ, Haylor J. Eicosanoids in renal function. Prostaglandins Leukot Essent Fatty Acids 1989;36:203-17.
25. lino Y, Imai M. Effects of prostaglandins on Na transport in isolated collecting-tubules. Pflugers Arch 1978;373:125-32.
26. Stokes JB. Effect of prostaglandin E2 on chloride transport across the rabbit thick ascending limb of Henle. J Clin Invest 1979;64:495-502.
27. Holt NF, Lechene C. ADH-PGE2 interactions in the cortical collecting tubule. II. Inhibition of Ca and P reabsorption. Am J Physiol 1981;241:P461-7.
28. Dunn MJ. Renal prostaglandins. In: Dunn MJ, editor. Renal endocrinology. Baltimore/London: Williams and Wilkins. 1983:1-74.
29. Muthur RS, Potter DM, Bennett WM. Aspirin-induced depression of glomerular filtration rate in normal humans: Role of sodium balance. Ann Intern Med 1981;94:317-21.
30. Harris RN, Yager WE. Renal function after release of unilateral ureteral obstruction. Am J Physiol 1974;227:806-15.
31. Olsen UB, Magnussen MP, Eilersten E. Prostaglandins: a link between renal hydro and haemodynamics in dogs. Acta Physiol Scand 1976;97:369-76.
32. Nishikawa K, Morrison A, Needleman P. Exaggerated prostaglandin biosynthesis and its influence on renal resistance in the isolated hydronephrotic rabbit kidney. J Clin Invest 1977;59: 1143-50
33. Currie M, Kawasaki A, Jonas P, Davis B, Needleman P. The mechanism and site of the enhanced arachidonate metabolism in ureter obstruction. In: Dunn MJ, Patrono C, Cinotti GA, editors. Prostaglandins and the Kidney, Biochemistry, Physiology, Pharmacology and Clinical Applications. New York/London. Plenum Medical Book Co, 1983:299-308.
34. Donker AJM, deJong PF, Statius van Eps LW, Brentjens JRH, Bakker K, Doorenbos H. Indomethacin in Bartter's syndrome. Nephron 1977;19:200-13.
35. Betend L, David M, Vincent M, Hermier M, Franois R. Suc-cessful indomethacin treatment for 2 paediatric patients with severe tubulopathies. Helv Paediatr Acta 1979;34:339-44.
36. Edwards BR, Baer PG, Sutton RAL, Dirks JH. Micropuncture study of diuretic effects of sodium and chloride reabsorption in the dog nephron. J Clin Invest 1973;52:2418-27.
37. Coe FL, Kavalach AG. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med 1974; 219:1344-50.
38. Weber PC, Scherer B, Larsson C. Increase in free arachidonic acid by furosemide in man as the cause of prostaglandin and renin release. Eur J Pharmacol 1977;41:329-32.
39. Paulsrud JR, Miller ON. Inhibition of 15-OH prostaglandin dehydrogenase by several diuretic drugs. Fed Proc 1974;33:590-94.
40. Buck AC, Lote CJ, Sampson WF. The influence of renal prostaglandins on urinary calcium excretion in idiopathic urolithiasis. J Urol 1983;129:421-6.
41. Buck AC. The influence of renal prostaglandins on calcium metabolism in relation to the pathogenesis of idiopathic urolithiasis. Ph.D. thesis University of Wales, 1987.
42. Hirayama H, Ikegami K, Shimomura T, Yamamoto T. The possible role of prostaglandin E2 in the urinary stone formation. Proc XX Congress Int Soc Urol 1985;231-3.
43. Henriquez-La Roche C, Rodriguez-Iturbi B, Herrera J, Parra G. Increased urinary excretion of prostaglandin E2 in patients with idiopathic hypercalciuria is a primary phenomenon. Clin Sci 1988;75:581-7.
44. Calo L, Cantaro S, Marchini F, Giannini S, Castrignano R, Gambaro G et al. Is hydrochlorothiazide-induced hypocalciuria due to inhibition of prostaglandin E2 synthesis. Clin Sci 1990;78:321-5.
45. Anderson CK. Renal histological changes in stone formers and non-stone formers. In: Hodgkinson A, Nordin BEC, editors. Renal stone research symposium (Leeds 1968). London: J & A Churchill, 1969:133-6.
46. Boyce WH, Willard JW. Intranephronic calculosis in the human kidney. In: Finlayson B, Hench LL, Smith LH, editors. Urolithiasis: Physical Aspects. Washington, DC: Nat Acad of Sci 1972:183.
47. Burry AF, Axelsen RA, Trolove P, Saal JR. Calcification in the renal medulla. Human Pathol 1976;7:435-49.
48. Beer E. Lime deposits, especially the so called kalmetastasen in the kidney. Pathogenic Bacteria 1903;9:225-33.
49. Anderson L, MacDonald JR. The origin frequency and significance of microscopic calculi in the kidney. Surg Gynaecol Obstet 1946;82:275-80.
50. Weinberg JM. Calcium as a mediator of renal tubule cell injury. Semin Nephrol 1984;4:174-91.
51. Cheung JY, Bonventre JV, Malis CD, Leaf A. Calcium and ischaemic injury. N Engl J Med 1986;314:1670-5.
52. Wilson DR, Arnold PE, Burke TJ, Shrier RW. Mitochondrial calcium accumulation and respiration in ischaemic acute renal failure in the rat. Kidney Int 1984;25:519-26.
53. Schrier RW, Arnold PE, van Putten VJ, Burke TJ. Cellular calcium in acute renal failure: Role of calcium entry blockers. Kidney Int 1987;32:313-21.
54. Burke TJ, Arnold PE, Gordon JA, Bulger RE, Dobyan DC, Schrier RW. Protective effect of intrarenal calcium membrane blockers before or after renal ischaemia. Functional, morphological and mitochondrial studies. J Clin Invest 1984;74:1830-41.
55. Wilson PD, Schrier RW. Nephron segment and calcium as determinants of anoxic cell death in primary renal cell cultures. Kidney Int 1986;29:1172-9.
56. Buck AC, Davies RL, Leaker B, Moffat DB. Inhibition of experimental nephrocalcinosis with a prostaglandin synthetase inhibitor. Br J Urol 1983;55:603-8.
57. Sinclair HM. The relative importance of essential fatty acids of the linoleic and linolenic families: studies with and Eskimo diet. Prog Lipid Res 1982;20:897-9.
58. Kromann N, Green A. Epidemiological studies in the U pernavik district, Greenland. Acta Med Scand 1980;208:401-6.
59. Bjerregaard P, Dyerberg J. Lipid metabolism and ischaemic heart disease in Greenland Eskimos. Int J Epidemiol 1988;17:514-9.
60. Middaugh JP. Cardiovascular deaths among Alaskan natives. Am J Public Health 1990;80:282-5.
61. Newman WP, Midhaugh JP, Propst MT, Rogers DR. Atherosclerosis in Alaska natives and non-natives. Lancet 1993;341:1056-7.
62. Hoffman P, Mest H-J. What about the effects of dietary lipids on endogenous prostanoid synthesis? A state of the art review. Biomed Biochim Acta 1987;46:639-50.
63. Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR. Eiscosapentaenoic acid and prevention of thrombosis and atherosclerosis. Lancet 1978;ii:117-9.
64. Throngren M, Gustafson A. Effects of 11 weeks increase in dieta eicosapentaenoic acid on bleeding time, lipids and platelet aggregation. Lancet 1981;ii:1190-4.
65. Hwang DH, Carrol AE. Decreased formation of prostaglandins derived from arachidonic acid by dietary liolenate in rats. Am J Clin Nutr 1980;33023-30.
66. Hwang DH, Bourdeau M, Chanmugan P. Dietary linolenic acid and longer-chain n-3 fatty acids: Comparison of effects on arachidonic acid metabolism in rats. J Nutr 1988;118:427-37.
67. Croft KD, Beilin LJ, Vandongen R, Matthews E. Dietary modifications of fatty acids and prostaglandin synthesis in the rat. Biochim Biophys Acta 1984;795:196-207.
68. Croft KD, Beilin LJ, Legge FM, Vandongen R. Effects of diets enriched in eicosapentaenoic or docosahexaenoic acids on prostanoid metabolism in rats. Lipids 1987;22:647-50.
69. Sanders TAB, Roshanai F. The influence of different types of ω-3 polyunsaturated fatty acids on blood lipids and platelet function in healthy volunteers. Clin Sci 1983;64:91-9.
70. Lee TH, Hoover RL, Williams JD, Sperling RI, Ravelese J, Spur BW et al. Effects of dietary eicosapentaenoic and docosahexaenoic acid on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985;312:1217-24.
71. Simonsen T, Nordoy A, Sjunneskog C, Lyngmo V. The effect of cod liver oil on two populations with low and high intake of dietary fish Acta Med Scand 1988;223:491-8.
72. Moncada S, Gryglewski R, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976;263: 663-5.
73. Needleman P, Raz A, Minkes MS, Ferrendelli JA, Sprecher H. Triene prostaglandins: prostacyclin and thrombocane biosynthesis and unique biological properties. Proc Nat Acad Sci USA 1979;76:944-8.
74. Gibson R A. The effects of diets containing fish and fish oils on disease risk factors in humans. Aust NZ J Med 1988;18:713-22.
75. Terrano T, Salmon JA, Moncada S. Effect of orally administered eicosapentaenoic acid (EPA) on the formation of leukotriene B4 and leukotriene BS by rat leukocytes. Biochem Pharmacol 1984;33:3071-6
76. Lee TH, Mencia-Huerta JM, Shih C, Corey EJ, Lewis RA, Austen KF. Characterization and biologic properties of 5-12 dihydroyderivatives of eicosapentaenoic acid, including leukoriene 135 and the double lipoxygenase Product. J Biol Chem 1984;259:2383-9.
77. Buck AC, Davies RL, Harrison T. The protective role of eicosapentaenoic acid (EPA) in the pathogenesis of nephrocalcinosis. J Urol 1991;146:188-94.
78. Bronsgeest-Schoute HC, vanGent CM, Luten JB, Ruiter A. The effect of various intakes of ω-3 fatty acids on the blood lipid composition in healthy human subjects. Am J Clin Nutr 1981;34:1727-52.
79. Fehily AM, Burr ML, Phillips KM, Deadman NM. The effect of fatt fish on plasma lipid and lipoprotein concentrations Am J Clin Nutr 1983;38:349-51.
80. Phillipson BE, Rothrock DW, Connor WF, Harris WS, Illingworth DR. Reduction of plasma lipids, lipoproteins and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med 1985;312:1210-6.
81. Buck AC, Smellie WS, Jenkins AC, Meddings R, Horrobin D. The treatment of idiopathic recurrent urolithiasis with fish oil and evening primrose oil. In: Ryall R et al., editors. Urolithiasis 2. New York: Plenum Press, 1994;575-80.
82. Blacklock NJ. Epidemiology [Urolithiasis]. In: Chisholm GD, Williams DI, editor. Scientific foundations of urology. Chicago: William Heinemann Med Books, 1982:1-9.
83. Bang HO, Dyerberg J. Personal reflections on the incidence of ischaemic heart disease in Oslo during the second World War. Acta Med Scan 1981;210:245-8.